Menu
/REGISTER
Montecito
Nixon Peabody
Chase
Bank of America
Loading...
You are here:  Home  >  Biotech  >  Current Article

Atara to raise $175M in secondary public offering

By   /   Wednesday, May 27th, 2020  /   Comments Off on Atara to raise $175M in secondary public offering

    Print       Email
Thousand Oaks immunotherapy maker Atara Biotherapeutics announced plans to raise $175.5 million in a secondary public offering. The company filed with the Securities and Exchange Commission to conduct an underwritten public offering of 12.6 million shares of common stock at $11.32 per share. Another 2.9 million in pre-funded warrants are being offered to other investors,…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Mindbody’s Stollmeyer to be executive chair of the board

Read More →